checkAd

     259  0 Kommentare Genkyotex Reports Progress of Setanaxib Phase 2 Investigator Initiated Trials - Seite 4

    Media relations Investor relations
    Sophie Baumont Brian Ritchie
    LifeSci Advisors LifeSci Advisors, LCC
    +33 6 2774 74 49 +1 212 915 2578
    sophie@lifesciadvisors.com britchie@lifesciadvisors.com

    http://ml.globenewswire.com/Resource/Download/853de2db-84e8-401e-9865- ...

    Lesen Sie auch



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Genkyotex Reports Progress of Setanaxib Phase 2 Investigator Initiated Trials - Seite 4 Phase 2 DKD trial funded by JDRF to expand in Europe and New Zealand13 patients have completed full 48-week treatment in DKD trial; no safety signals identifiedPhase 2 IPF trial funded by NIH; poised to initiate patient enrollment following recently …